[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 5, Issue 2 (12-2006) ::
3 2006, 5(2): 87-0 Back to browse issues page
Emerging Drug Therapies for Heart Failure
Pitchai Balakumar , Manjeet Singh
Abstract:   (132 Views)
Heart failure is associated with high morbidity and mortality and is proving to be an economic burden in developing countries. A number of therapeutic agents are presently employed in heart failure; but they are not sufficient to control symptoms of heart failure. Moreover, the prevalence of chronic heart failure is progressively increasing and thus there is a continuing need to develop effective therapies for the management of this disease. The present review has discussed various potential therapeutic agents which may open new vistas for the management of heart failure.
Keywords: Heart failure, Candisartan, Spironolactone, Conivaptan, Nesiritide, Omapatrilat
Full-Text [PDF 478 kb]   (65 Downloads)    
Article Type: Research Article |
Add your comments about this article
Your username or Email:

CAPTCHA code


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Balakumar P, Singh M. Emerging Drug Therapies for Heart Failure. 3. 2006; 5 (2) :87-0
URL: http://ijpt.iums.ac.ir/article-1-100-en.html


Volume 5, Issue 2 (12-2006) Back to browse issues page
مجله داروشناسی و درمان شناسی ایران Iranian Journal of Pharmacology and Therapeutics
Persian site map - English site map - Created in 0.22 seconds with 33 queries by YEKTAWEB 3731